![Angold Resources Ltd](/common/images/company/TX_AAU.png)
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9) after up to four years of...
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | -0.05 | -25 | 0.2 | 0.2 | 0.15 | 12818 | 0.163134 | CS |
52 | 0.08 | 114.285714286 | 0.07 | 0.25 | 0.04 | 28601 | 0.11284763 | CS |
156 | -0.115 | -43.3962264151 | 0.265 | 0.29 | 0.005 | 188803 | 0.09038779 | CS |
260 | -0.33 | -68.75 | 0.48 | 0.53 | 0.005 | 198390 | 0.16143363 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.